Comparison of in vivo eccentricity and symmetry indices between metallic stents and bioresorbable vascular scaffolds: Insights from the ABSORB and SPIRIT trials

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 2, 2012, Pages 219-228

  Brugaletta, Salvatore ^a,b   Gomez Lara, Josep ^a   Diletti, Roberto ^a   Farooq, Vasim ^a   Jan Van Geuns, Robert ^a   De Bruyne, Bernard ^c   Dudek, Dariusz ^d   Garcia Garcia, Hector M ^a,e   Ormiston, John A ^f   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BARCELONA   (Spain)

^c OLV Clinic   (Belgium)

^d JAGIELLONIAN UNIVERSITY   (Poland)

^e CARDIALYSIS   (Netherlands)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

BVS; eccentricity; IVUS; symmetry; XIENCE V

Indexed keywords

CALCIUM;

ADULT; ARTICLE; BIODEGRADABLE IMPLANT; BIORESORBABLE VASCULAR SCAFFOLD; CALCULATION; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DEVICES; FEMALE; GEOMETRY; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; METALLIC STENT; PERCUTANEOUS CORONARY INTERVENTION; STENT;

EID: 84856255048     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22996     Document Type: Article

References (33)

1. Goldberg SL, Colombo A, Nakamura S, Almagor Y, Maiello L, Tobis JM,. Benefit of intracoronary ultrasound in the deployment of Palmaz-Schatz stents. J Am Coll Cardiol 1994; 24: 996-1003. (Pubitemid 24306410)
2. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation 1996; 93: 412-422. (Pubitemid 26043599)
3. de Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, Penn I, Colombo A, Hamm C, Bartorelli A, Rothman M, et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the multicenter ultrasound stenting in coronaries study (MUSIC Study). Eur Heart J 1998; 19: 1214-1223. (Pubitemid 28362605)
4. Serruys PW, Kay IP, Disco C, Deshpande NV, de Feyter PJ,. Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: Results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I. BENESTENT II Pilot, BENESTENT II, and MUSIC trials. Multicenter ultrasound stent in coronaries. J Am Coll Cardiol 1999; 34: 1067-1074. (Pubitemid 29500540)
5. de Feyter PJ, Kay P, Disco C, Serruys PW,. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation 1999; 100: 1777-1783. (Pubitemid 29498383)
6. Otake H, Shite J, Ako J, Shinke T, Tanino Y, Ogasawara D, Sawada T, Miyoshi N, Kato H, Koo BK, et al. Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. JACC Cardiovasc Interv 2009; 2: 459-466.
7. Serruys PW, Ong AT, Piek JJ, Neumann FJ, van der Giessen WJ, Wiemer M, Zeiher A, Grube E, Haase J, Thuesen L, et al. A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT I trial. EuroIntervention 2005; 1: 58-65.
8. Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carrie D, Thuesen L, et al. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: The SPIRIT II trial. EuroIntervention 2006; 2: 286-294.
9. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S,. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): A prospective open-label trial. Lancet 2008; 371: 899-907. (Pubitemid 351384734)
10. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hebert K, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009; 373: 897-910.
11. Serruys PW, Onuma Y, Ormiston JA, de Bruyne B, Regar E, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, et al. Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: Six-month clinical and imaging outcomes. Circulation 2010; 122: 2301-2312.
12. Reiber JH, Serruys PW,. Quantitative Coronary Angiography: Methodologies. Quantitative Coronary Angiography. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1991, Vol. 98. p 102.
13. Okamura T, Garg S, Gutierrez-Chico JL, Shin ES, Onuma Y, Garcia HM, Rapoza R, Sudhir K, Regar E, Serruys PW,. In-vivo evaluation of stent strut distribution patterns in the bioabsorbable everolimus-eluting device: An OCT ad hoc analysis of the Revision 1.0 and Revision 1.1 stent design in the ABSORB clinical trial. EuroIntervention 2010: 932-938.
14. Hamers R, Bruining N, Knook M, Sabate M,. A novel approach to quantitative analysis of intravascular ultrasound images. Computers Cardiol 2008; 28: 589-592.
15. Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: An integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent trials. JACC Cardiovasc Interv 2009; 2: 1269-1275.
16. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: Serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol 2004; 43: 1959-1963. (Pubitemid 38686788)
17. Tsuchida K, Garcia-Garcia HM, Ong AT, Valgimigli M, Aoki J, Rademaker TA, Morel MA, van Es GA, Bruining N, Serruys PW,. Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: Analysis from the SPIRIT I trial. Catheter Cardiovasc Interv 2006; 67: 188-197. (Pubitemid 43235149)
18. Costa MA, Sabate M, Kay IP, de Feyter PJ, Kozuma K, Serrano P, de Valk V, Albertal M, Ligthart JM, Disco C, et al. Three-dimensional intravascular ultrasonic volumetric quantification of stent recoil and neointimal formation of two new generation tubular stents. Am J Cardiol 2000; 85: 135-139. (Pubitemid 30026091)
19. Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 2001; 37: 1478-1492.
20. Mintz GS, Pichard AD, Popma JJ, Kent KM, Satler LF, Bucher TA, Leon MB,. Determinants and correlates of target lesion calcium in coronary artery disease: A clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol 1997; 29: 268-274. (Pubitemid 27059954)
21. Kostamaa H, Donovan J, Kasaoka S, Tobis J, Fitzpatrick L,. Calcified plaque cross-sectional area in human arteries: Correlation between intravascular ultrasound and undecalcified histology. Am Heart J 1999; 137: 482-488. (Pubitemid 29124116)
22. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, Ditrano CJ, Leon MB,. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation 1995; 91: 1959-1965.
23. Schmidt W, Lanzer P, Behrens P, Topoleski LD, Schmitz KP,. A comparison of the mechanical performance characteristics of seven drug-eluting stent systems. Catheter Cardiovasc Interv 2009; 73: 350-360.
24. Sangiorgi G, Melzi G, Agostoni P, Cola C, Clementi F, Romitelli P, Virmani R, Colombo A,. Engineering aspects of stents design and their translation into clinical practice. Ann Ist Super Sanita 2007; 43: 89-100.
25. Rieu R, Barragan P, Garitey V, Roquebert PO, Fuseri J, Commeau P, Sainsous J,. Assessment of the trackability, flexibility, and conformability of coronary stents: A comparative analysis. Catheter Cardiovasc Interv 2003; 59: 496-503. (Pubitemid 36927444)
26. Tanimoto S, Serruys PW, Thuesen L, Dudek D, de Bruyne B, Chevalier B, Ormiston JA,. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials. Catheter Cardiovasc Interv 2007; 70: 515-523. (Pubitemid 47597022)
27. Gomez-Lara J, Garcia-Garcia HM, Onuma Y, Garg S, Regar E, De Bruyne B, Windecker S, McClean D, Thuesen L, Dudek D, et al. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents. JACC Cardiovasc Interv 2010; 3: 1190-1198.
28. Kim SW, Mintz GS, Hong YJ, Pakala R, Park KS, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R, et al. The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol 2008; 102: 1182-1186.
29. Brugaletta S, Garcia-Garcia HM, Garg SJ, G-L, Diletti R, Onuma Y, Van Geuns RJ, McClean D, Dudek D, Thuesen L, Chevalier B, Windecker S, Whitbourn R, Dorange C, Miquel-Hebert K, Sudhir K, Ormiston JA, Serruys PW. Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffol. Int J Cardiovasc Imaging 2010, Oct 13 [epub ahead of print] (in press).
30. Alfonso F, Suarez A, Perez-Vizcayno MJ, Moreno R, Escaned J, Banuelos C, Jimenez P, Bernardo E, Angiolillo DJ, Hernandez R, et al. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol 2007; 50: 2095-2097. (Pubitemid 350087569)
31. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, Fitzgerald PJ, Yock PG,. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J 2002; 23: 124-132. (Pubitemid 35204230)
32. Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, Satler LF, Canos D, Castagna M, Weissman NJ, Waksman R,. Predictors of subacute stent thrombosis: Results of a systematic intravascular ultrasound study. Circulation 2003; 108: 43-47. (Pubitemid 36859018)
33. Alfonso F, Suarez A, Angiolillo DJ, Sabate M, Escaned J, Moreno R, Hernandez R, Banuelos C, Macaya C,. Findings of intravascular ultrasound during acute stent thrombosis. Heart 2004; 90: 1455-1459. (Pubitemid 39626325)